Pharmafile Logo
Pharmafocus logo
Advanced Search
Xgeva image

Xgeva gains NICE recommendation for bone metastasis

August 17, 2012
Sales and Marketing Amgen, NICE, Xgeva, bone metastatis

NICE is continuing to recommend Amgen’s Xgeva for certain groups of cancer patients whose disease has spread to their bones. …

News

Zaicom MMC appoints new medical writer

August 17, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Katharine Peregrín, Zaicom MMC

Comms agency Zaicom MMC, part of the Zaicom International group of companies, has appointed Katharine Peregrín as a medical writer.  …

Appointment
Novartis image

Novartis eye drug succeeds in Phase III trial

August 16, 2012
Sales and Marketing FDA, Novartis, Ocriplasmin, Roche, VMA

Novartis has posted positive results for its investigational eye drug ocriplasmin. The Phase III study found that ocriplasmin significantly resolved …

News
Pfizer image

Pfizer meets targets on greenhouse gases

August 16, 2012
Manufacturing and Production GHGs, Merck, Pfizer

Pfizer says it has fulfilled its goal of cutting environmentally-harmful emissions from its facilities by 20%, a year ahead of …

News

The number one reason for a failed project

August 16, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Communication, Failed project, Les Rose, clinical trials

There was once a company that had an amusing form of words for admonishing people. It went something like this: …

Feature

Boehringer posts strong financials

August 16, 2012
Sales and Marketing AMNOG, Boehringer, COPD, Spiriva

Boehringer Ingelheim has seen steady growth in the first half of 2012, but warns that the next six months may …

News

Catalent Announces Commencement of Supply of Abilify® Orally Disintegrating Tablets to Otsuka and Extensive Investments to Zydis® Technology Capabilities in Swindon, UK

August 16, 2012
Manufacturing and Production

Somerset, NJ, July 24, 2012 – Catalent announced it has commenced supply to Otsuka Pharmaceutical Co., Ltd. of Abilify® OD …

News
Press release

Catalent and Bend Research Partner to Provide Integrated Solutions for Oral Controlled-Release Technologies

August 16, 2012
Manufacturing and Production

Catalent Pharma Solutions, Inc. and Bend Research Inc. have entered into an agreement to provide integrated solutions for pharmaceutical companies …

News
Press release

Diabetes prescriptions jump by 50% in England

August 15, 2012
Sales and Marketing Humalog, Januvia, NHS, diabetes, spending

Diabetes prescriptions in England have for the first time topped 40 million this year, a rise of nearly 50% compared …

News
GSK HQ

GSK sheds Australian generics unit for £172m

August 15, 2012
Sales and Marketing Aspen Global, GSK, generics

GlaxoSmithKline has divested the majority of its Australian generics unit to Aspen Global, a firm it partly owns. The South …

News
Cream advert image

Genus reprimanded for ‘sexual and titillating’ advert

August 15, 2012
Sales and Marketing ABPI, Genus, PMCPA, breach, eczema

Genus has been found in breach of the ABPI Code after using a sexually charged image for the promotion of …

News

Smoke and fire in J&J Code breach

August 15, 2012
Sales and Marketing Champix, J&J, JJ, Johnson and Johnson, PMCPA, Pfizer

Johnson & Johnson has been censured for breaking the ABPI Code of Practice in printed information about its smoking cessation …

News
Patientslike me image

MSD joins forces with PatientsLikeMe for psoriasis

August 14, 2012
Medical Communications MSD, Novartis, PatientsLikeMe, digital, psoriasis

MSD has teamed up with the online patient community site ‘PatientsLikeMe’ to gauge the impact of psoriasis on patients, whilst …

News
Tsyabri image

Elan to spin off drug discovery arm

August 14, 2012
Research and Development, Sales and Marketing Elan, Neotype Biosciences, Tysabri, multiple sclerosis

Elan Corporation is to spin off its drug discovery arm Neotype Biosciences to create a separate, quoted company by the …

News
novartis_window

New Avastin data could be bad news for Lucentis

August 14, 2012
Research and Development, Sales and Marketing DMO, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

The day after Novartis gained a new US licence for Lucentis to treat diabetic macular oedema, new data was published …

News

China sets February 2013 deadline for excipient regulations

August 14, 2012
Manufacturing and Production China, IPEC, SFDA, Taylor

China has moved swiftly ahead with new regulations governing quality rules for pharmaceutical excipients, including new requirements for pharma firms …

News
dr_susan_wood

Astellas Pharma Europe appoints new senior director

August 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Susan Wood

Astellas Pharma Europe has appointed Dr Susan Wood as senior director, Market Access. Formerly senior brand director of APEL’s Pain Management …

Appointment

Acino plant opens to serve Bayer contraceptive patch needs

August 14, 2012
Manufacturing and Production Acino, Bayer, R&D, Swiss, contraceptive

Acino has officially opened its new manufacturing facility for transdermal patch products in Miesbach, Germany, which it says makes it …

News

Novartis pledges to maintain R&D presence in Horsham

August 14, 2012
Manufacturing and Production, Research and Development Horsham, NIBR, Novartis, R&D, cuts

Novartis has confirmed that it intends to maintain a presence at its site in Horsham, UK, which has already seen …

News
Nexium image

Pfizer pays $250m for OTC Nexium rights

August 14, 2012
Sales and Marketing AstraZeneca, EMA, FDA, Nexium, OTC, Pfizer

Pfizer will pay $250 million to AstraZeneca in order to gain the rights to sell an over-the-counter form of the …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026